Planning Capital Management Corp Raises Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Planning Capital Management Corp raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 83.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 121 shares of the biotechnology company’s stock after purchasing an additional 55 shares during the quarter. Planning Capital Management Corp’s holdings in Axon Enterprise were worth $48,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Axon Enterprise by 2.7% in the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares in the last quarter. 1832 Asset Management L.P. lifted its holdings in shares of Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after buying an additional 114,800 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Axon Enterprise by 13.9% in the second quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock worth $108,496,000 after buying an additional 45,049 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Axon Enterprise by 1.6% in the second quarter. Thrivent Financial for Lutherans now owns 270,430 shares of the biotechnology company’s stock worth $79,571,000 after buying an additional 4,365 shares in the last quarter. Finally, Federated Hermes Inc. lifted its holdings in shares of Axon Enterprise by 14.5% in the second quarter. Federated Hermes Inc. now owns 234,185 shares of the biotechnology company’s stock worth $68,907,000 after buying an additional 29,680 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, President Joshua Isner sold 25,811 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now owns 228,166 shares in the company, valued at $82,103,253.44. This represents a 10.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the transaction, the chief executive officer now owns 3,015,366 shares in the company, valued at approximately $1,121,052,771.48. This trade represents a 2.59 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 411,006 shares of company stock valued at $161,360,618 over the last three months. 6.10% of the stock is owned by company insiders.

Axon Enterprise Stock Up 0.5 %

Shares of AXON opened at $604.56 on Friday. The firm has a market capitalization of $46.10 billion, a P/E ratio of 156.22, a P/E/G ratio of 15.10 and a beta of 0.94. Axon Enterprise, Inc. has a 12-month low of $220.77 and a 12-month high of $624.84. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm has a fifty day moving average price of $433.89 and a 200-day moving average price of $355.28.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Robert W. Baird boosted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Craig Hallum boosted their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Barclays boosted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. JMP Securities boosted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Finally, Northland Securities boosted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.